首页>
外国专利>
PERFLUORINATED BLOOD SUBSTITUTE - GAS TRANSPORT DONOR BLOOD SUBSTITUTE: FORMULATION AND TREATMENT
PERFLUORINATED BLOOD SUBSTITUTE - GAS TRANSPORT DONOR BLOOD SUBSTITUTE: FORMULATION AND TREATMENT
展开▼
机译:全血替代品-天然气运输供体血液替代品:配方和治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to pharmaceutical industry and represents a formulation of a perfluorinated blood substitute emulsion for biomedical applications, containing: perfluorinated hydrocarbons, emulsifying agents and an electrolyte solution differing by the fact that it contains a binary mixture of two perfluorinated hydrocarbons in ratio 1.55 to 1.99 in the concentration of 5 - 1000 g/l, with an average particle size of a perfluororganic compound of 25 - 250 nm; a binary mixture of the emulsifying agents in ratio 1.55 to 1.99 that are non-ionic block copolymers of ethylene oxide and propylene oxide - proxanoles: proxanole-268/proxanole-168; proxanole-268 in the concentration of 1 - 200 g/l with the molecular weight of 7 - 14 thousand Da; proxanole-168 in the concentration of 1 - 200 g/l with the molecular weight of 5 - 7 thousand Da; the electrolyte solution: NaH2PO4 - 0.18-0.25 g/l; NaCl - 5.5-6.5 g/l; and/or KCl - 0.37-0.41 g/l; and/or MgCl2 - 0.17-0.21 g/l; and/or NaHCO3 - 0.35-0.7 g/l; and/or glucose - 1.5-2.5 g/l.;EFFECT: invention ensures formulating the perfluorinated blood substitute with better aggregation and sedimentation stability and lower toxicity.;2 cl, 9 ex
展开▼
机译:领域:本发明涉及制药工业,并且代表了用于生物医学应用的全氟化血代乳剂的制剂,其包含:全氟化烃,乳化剂和电解质溶液,其不同之处在于其包含以下成分的二元混合物:两种全氟烃,其比率为1.55至1.99,浓度为5-1000 g / l,全氟有机化合物的平均粒径为25-250 nm;乳化剂的比例为1.55-1.99的二元混合物,它们是环氧乙烷和环氧丙烷的非离子嵌段共聚物-普鲁沙醇类:普萘洛尔268 /普萘洛尔168浓度为1-200 g / l,分子量为7-14000 Da的proxanole-268;浓度为1-200 g / l,分子量为5-7 000 Da的proxanole-168;电解液:NaH 2 Sub> PO 4 Sub>-0.18-0.25 g / l;氯化钠-5.5-6.5克/升;和/或KCl-0.37-0.41 g / l;和/或MgCl 2 Sub>-0.17-0.21 g / l;和/或NaHCO 3 Sub>-0.35-0.7 g / l;和/或葡萄糖-1.5-2.5 g / l 。;效果:本发明确保配制具有更好的聚集和沉降稳定性并降低毒性的全氟血液代用品。; 2 cl,9 ex
展开▼